Home Medicine Amikacin alters auditory brainstem conduction time in newborns
Article
Licensed
Unlicensed Requires Authentication

Amikacin alters auditory brainstem conduction time in newborns

  • A. Poblano , A. Belmont , J. Sosa , J. Ibarra , A. M. Vargas , G. Limón and C. Martínez
Published/Copyright: June 1, 2005
Journal of Perinatal Medicine
From the journal Volume 31 Issue 3

Abstract

The purpose of this paper was to describe whether there are some relationships between amikacin serum levels and central conduction time in brainstem auditory evoked potentials (BAEP) within therapeutic range levels in newborns as index of drug toxicity in brainstem auditory centers in neonatally exposed infants. We performed a cross-sectional study to compare BAEP from 35 infants under amikacin administration and 24 control infants; both examinations were blinded to investigators. Bivariate and partial correlations were calculated between amikacin and BAEP measurements in treated infants. Amikacin determinations were within therapeutic levels.No clinical alterations in BAEP were found and no differences between amikacin-treated and control infants were found. Significant positive Pearson correlation between latency of I-III interwaves interval and amikacin Cmin serum levels was found and was present when calculations were controlled by partial correlations for gestational age at birth and Apgar score at 5 min.The findings suggest that increased amikacin levels in newborns are related to increased latencies in I-III interwave interval in infants, which may be an early index of brainstem effects of subclinical neurotoxicity of amikacin.

:
Published Online: 2005-06-01
Published in Print: 2003-05-14

Copyright © 2003 by Walter de Gruyter GmbH & Co. KG

Downloaded on 31.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/JPM.2003.032/pdf
Scroll to top button